808770-39-0

Basic information

• Product Name: 6-Chloro-4-Methoxy-pyridazin-3-ylaMine
• Synonyms: 6-Chloro-4-Methoxy-pyridazin-3-ylaMine;6-Chloro-4-Methoxypyridazin-3-aMine;6-chloro-4-methoxy-3-Pyridazinamine
• CAS NO: 808770-39-0
• Molecular Formula: C₅H₆ClN₃O
• Molecular Weight: 159.57364
• EINECS: -0
• Mol File: 808770-39-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 6-Chloro-4-Methoxy-pyridazin-3-ylaMine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Chloro-4-Methoxy-pyridazin-3-ylaMine(808770-39-0)
• EPA Substance Registry System: 6-Chloro-4-Methoxy-pyridazin-3-ylaMine(808770-39-0)

Safety Data

• Hazardous Substances Data: 808770-39-0(Hazardous Substances Data)

Usage

General Description

6-Chloro-4-Methoxy-pyridazin-3-ylaMine is a chemical compound with the molecular formula C5H5ClN2O, which contains a pyridazine ring with a chloride and a methoxy group attached. It is an organic compound that can be used in pharmaceutical research and drug development due to its potential biological activities. It may be used as a reactant in the synthesis of various organic compounds and may also have potential applications in the field of medicinal chemistry. The compound's structural features and functional groups make it a valuable building block for the production of new drugs and pharmaceuticals. Due to its potential applications, this chemical may be of interest to chemists, pharmacologists, and researchers in the pharmaceutical industry.

Upstream product

• 67-56-1 methanol 
• 446273-59-2 4-bromo-6-chloro-3-pyridazineamine 
• 124-41-4 sodium methylate 

Downstream Products

• 923595-82-8 6-chloro-8-methoxyimidazo[1,2-b]pyridazine 

Relevant articles and documents

IMIDAZOPYRIDAZINONE COMPOUNDS AND USES THEREOF

The present invention relates to imidazopyridazinone compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating autoimmune, inflammatory, and neurodegenerative diseases by administering

FUSED HETEROCYCLES AS LCK INHIBITORS

There is provided fused heterocycles of imidazopyridazine or pyrazolopyrimidine derivative represented by the formula (I), which have excellent Lck inhibitory activity and are useful for a medicament particularly an immunosuppressive agent. [wherein one of Y and Z is C atom, and the other is N atom; -X-10 is -N (R1) - or the like, -R1 is hydrogen or the like, -A- is bond or the like, is cycloalkyl, aryl or the like, -E- is bond or the like, -R3 is aryl, aromatic heterocycle or the like, -R4, -R5 and -R6 are the same or different, each being hydrogen or the like.]